Silver staining method for demonstrating Lewy bodies in Parkinson’s disease and argyrophilic oligodendrocytes in multiple system atrophy
- 21 January 1999
- journal article
- Published by Elsevier in Journal of Neuroscience Methods
- Vol. 87 (1) , 111-115
- https://doi.org/10.1016/s0165-0270(98)00173-3
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Silver Labeling of Alzheimer Neurofibrillary Changes and Brain β-AmyloidJournal of Histotechnology, 1993
- Four modified silver methods for thick sections of formaldehyde-fixed mammalian central nervous tissue: ‘dark’ neurons, perikarya of all neurons, microglial cells and capillariesJournal of Neuroscience Methods, 1993
- Immunohistochemical expression of microtubule-associated protein 5 (MAP5) in glial cells in multiple system atrophyJournal of the Neurological Sciences, 1992
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Neuronal inclusions of Parkinson's diseaseMovement Disorders, 1991
- Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- THE SIGNIFICANCE OF THE LEWY BODY IN THE DIAGNOSIS OF IDIOPATHIC PARKINSON'S DISEASENeuropathology and Applied Neurobiology, 1989
- Lewy bodies are ubiquitinatedActa Neuropathologica, 1988
- Silver Impregnation of Alzheimer's Neurofibrillary Changes Counterstained for Basophilic Material and Lipofuscin PigmentStain Technology, 1988
- Light Insensitive Physical DevelopersStain Technology, 1979